Biotechnology

Ark Biopharmaceutical Receives IND Approval from NMPA for AK0610, a Respiratory Syncytial Virus Neutralizing Antibody

SHANGHAI, Nov. 23, 2023 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announces that it had received IND approval from National Medical Products Administration (NMPA) for a novel antibody drug AK0610. This antibody drug is bioengineered based on a neutralizing antibody origina...

2023-11-23 08:00 2543

TurtleTree obtains the world's first self-GRAS for animal-free lactoferrin, LF+™ now approved to commercialize in the U.S.

This regulatory milestone sets the stage for U.S. commercialization in Q4 2023. Using precision fermentation, TurtleTree expects profitability on LF+ in 2024 and will address global supply scarcity. SACRAMENTO, Calif. and SINGAPORE, Nov. 23, 2023 /PRNewswire/ -- TurtleTree

2023-11-23 02:14 2716

CMI Inc. and Life Molecular Imaging Announce the Reimbursement of the Amyloid-PET Diagnostic Neuraceq® (florbetaben 18F) in Japan

First Reimbursed Amyloid PET Diagnostic Tool in Japan TOKYO and BERLIN, Nov. 23, 2023 /PRNewswire/ -- CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic  Neuraceq®  (florbetaben18F injection) has been approved from the Ministry of Health, Labor, and ...

2023-11-23 01:00 1889

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

* By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture to final UF/DF pool at pilot scale * This end-to-end continuous bioprocess, which is in place for WuXi Biologics global manufacturing network, is...

2023-11-22 13:21 3600

XtalPi and EDDC Sign New Collaboration, Empowering Biomedical Innovation with Robotics and Large Language Models

SHENZHEN, China, Nov. 22, 2023 /PRNewswire/ -- Today, XtalPi announced that it has signed a Memorandum of Understanding (MOU) with the Experimental Drug Development Centre (EDDC),Singapore's national drug discovery and development platform hosted by A*STAR, for the expansion of their collaboratio...

2023-11-22 09:00 2386

Origin Agritech Provides Business Updates and Answers Questions from Investors

Preannounces Approximately 70% Increase in Revenues for Fiscal Year 2023 BEIJING, Nov. 21, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, provided investors with a business update and provided preliminary fi...

2023-11-21 22:00 3610

HeiQ unveils HeiQ Skin Care - a probiotics-infused textile technology

ZÜRICH, Nov. 21, 2023 /PRNewswire/ -- HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market.The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the hu...

2023-11-21 16:00 1752

JUMPSTARTER 2023 Tech by the Harbour Successfully Concludes

Allegrow Biotech in Biotech and Life Science Industry crowned champion of JUMPSTARTER 2023 Global Pitch Competition Two-week public event attracts over 100,000 participants HONG KONG, Nov. 21, 2023 /PRNewswire/ -- JUMPSTARTER, organized by Alibaba Hong Kong Entrepreneurs Fund ("AEF"), held its f...

2023-11-21 15:23 1922

ST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop

SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the Korea-CEPI R&D Workshop in World Bio Summit 2023, organized by Korea Health Industry Development...

2023-11-21 12:00 1401

CARsgen Announces Formation of its Clinical Advisory Board

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the formation of its Clinical Advisory Board. This highly regarded pa...

2023-11-20 21:50 2727

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

The power of advanced metabolomic analytical techniques can now be applied to a broader array of diverse academic and commercial life science research MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions adva...

2023-11-20 21:03 1305

Viva Biotech Secures Approximately US$ 210 Million Funding

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Viva Biotech Holdings Group (1873. HK) announced thatit completed a funding round, securing approximatelyUS$210 million and bringing in the strategic investors, Temasek, Highlight Capital (HLC), and True Light. Following this transact...

2023-11-20 20:04 2767

Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging

SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell therapy, and accelerate the application of NK cells in ca...

2023-11-20 20:00 1220

First Subject Enrolled in Phase 1 Study of MRX-5

SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as "MicuRx") announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...

2023-11-20 18:34 1458

GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023

Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...

2023-11-20 14:39 1432

Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.

SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...

2023-11-18 08:00 3082

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologie...

2023-11-17 22:21 3765

The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS

The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Institute of Human Gene...

2023-11-17 21:02 1648

Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference

Using single cell multi-omics analysis to predict treatment outcome, develop disease prognostics and track patient responses to CAR T therapies COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies , a company at the forefront of developing and commerc...

2023-11-17 17:58 1409

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ("CRDMO") focused on antibody drug conjugates ("ADC") and the broader bioconjugate market, listed on the...

2023-11-17 14:00 2984
1 ... 66676869707172 ... 306

Week's Top Stories